Taxus Cardium Pharmaceuticals Executives

CRXMDelisted Stock  USD 0.0001  0.00  0.00%   
Taxus Cardium employs about 3 people. The company is managed by 6 executives with a total tenure of roughly 21 years, averaging almost 3.0 years of service per executive, having 0.5 employees per reported executive. Analysis of Taxus Cardium's management performance can provide insight into the firm performance.
Christopher Reinhard  CEO
Co-Founder, CEO and President Treasurer and Executive Director
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.

Taxus Cardium Management Team Effectiveness

The company has return on total asset (ROA) of (2.619) % which means that it has lost $2.619 on every $100 spent on assets. This is way below average. Taxus Cardium's management efficiency ratios could be used to measure how well Taxus Cardium manages its routine affairs as well as how well it operates its assets and liabilities.

Taxus Cardium Workforce Comparison

Taxus Cardium Pharmaceuticals is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 3,901. Taxus Cardium adds roughly 3.0 in number of employees claiming only tiny portion of equities under Health Care industry.

Taxus Cardium Notable Stakeholders

A Taxus Cardium stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Taxus Cardium often face trade-offs trying to please all of them. Taxus Cardium's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Taxus Cardium's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Christopher ReinhardCo-Founder, CEO and President Treasurer and Executive DirectorProfile
Ronald ShebuskiChief OfficerProfile
Lois ChandlerChief OfficerProfile
Duane LinstromG CounselProfile
James GrainerCFO ChairmanProfile
Kelly ScottVP IncProfile

About Taxus Cardium Management Performance

The success or failure of an entity such as Taxus Cardium Pharma often depends on how effective the management is. Taxus Cardium management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Taxus management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Taxus management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Gene Biotherapeutics, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of angiogenic gene therapy biotherapeutics for the treatment of cardiovascular diseases in the United States. Gene Biotherapeutics, Inc. was incorporated in 2003 and is headquartered in San Diego, California. Taxus Cardium operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 3 people.

Taxus Cardium Workforce Analysis

Traditionally, organizations such as Taxus Cardium use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Taxus Cardium within its industry.

Taxus Cardium Manpower Efficiency

Return on Taxus Cardium Manpower

Revenue Per Employee0.0
Revenue Per Executive0.0
Net Loss Per Employee172.6K
Net Loss Per Executive86.3K
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Other Consideration for investing in Taxus Pink Sheet

If you are still planning to invest in Taxus Cardium Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Taxus Cardium's history and understand the potential risks before investing.
Transaction History
View history of all your transactions and understand their impact on performance
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Commodity Directory
Find actively traded commodities issued by global exchanges
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities